Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings ...
On Tuesday, Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted ...
For TW, they had the tough task of taking on HomeBois, while TS was facing off against Liquid Echo. In the end ... This series was another quick one, with TLPH absolutely destroying HB, constantly ...